HOT TOPICS
Clinical & Pharma
Kidney disease patients rely on numerous pharmaceuticals—including erythropoiesis-stimulating agents (ESAs),iron, Vitamin D, phosphate binders and calcium—to ensure proper care. In addition, new clinical research is released on a regular basis by nephrologists and other doctors to advance the field of nephrology.
-
Quality of Life and Treatment Of Late-Stage CKD
Posted in News, Clinical & Pharma
-
New Blood Test Detects Potentially Deadly Calcium Deposits
Posted in News, Clinical & Pharma
-
Simple Blood Tests Detect Autoimmune Kidney Disease, Help Predict Prognosis
Posted in News, Clinical & Pharma
-
Some Patients with Common Kidney Disease Can Skip Standard Treatments
Posted in News, Clinical & Pharma
-
AlloCure Begins Phase 2 Clinical Trial in AKI
Posted in News, Clinical & Pharma
-
Aging Kidneys May Hold Key to New High Blood Pressure Therapies
Posted in News, Clinical & Pharma
-
Kidneys Not an Issue for Apixaban
Posted in News, Clinical & Pharma
-
Proteinuria in CKD Patients May Indicate a Need for Intensive Sodium Restriction
Posted in News, Clinical & Pharma
-
Too Early to Make a Call on CKD Screening
Posted in News, Clinical & Pharma, Practice Management
-
Hemodialysis Patient Death Risk Linked to CAC on CXR
Posted in News, Clinical & Pharma